Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin

Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin

Hepatitis E virus (HEV) is increasingly recognized as the leading cause of acute hepatitis. Although HEV infections are mostly self-limiting, a chronic course can develop especially in those with immunocompromised state. Ribavirin is currently used to treat such patients. According to various report...

Full description

Bibliographic Details
Main Authors: Putu Prathiwi Primadharsini, Shigeo Nagashima, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Viruses
Subjects:
hepatitis E virus
ritonavir
virus internalization
ribavirin
drug combination
in vitro
Online Access:https://www.mdpi.com/1999-4915/14/11/2440

Internet

https://www.mdpi.com/1999-4915/14/11/2440

Similar Items